abstract |
The invention relates to novel sulfonamide derivatives of formula (I) wherein R 2, R 3, R 4, A, X, Y 1, Y 2, Y 3, Y 4 and Z 1 are as defined in the description and claims as well as their derivatives. physiologically acceptable salts and esters. These compounds inhibit L-CPT1 and may be used as medicines. |